Home > Journals > Italian Journal of Vascular and Endovascular Surgery > Past Issues > Italian Journal of Vascular and Endovascular Surgery 2014 December;21(4) > Italian Journal of Vascular and Endovascular Surgery 2014 December;21(4):201-4

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

  PERIPHERAL ARTERIAL DISEASES 

Italian Journal of Vascular and Endovascular Surgery 2014 December;21(4):201-4

Copyright © 2014 EDIZIONI MINERVA MEDICA

language: English

Directional atherectomy and adjunctive drug-coated balloon angioplasty

Sixt S. 1, Zeller T. 2

1 Angiologikum, Center for Interventional Angiology, Medical Care Prof. Mathey/Prof. Schofer, Hamburg, Germany; 2 University Heart Center, Freiburg Bad Krozingen, Bad Krozingen, Germany


PDF


The safety and efficiency of directed atherectomy (DA) have consistently been demonstrated in multiple clinical trails. The mechanical excision of the intima, however, seems to induce a reasonable inflammatory response which limit the long term clinical benefit. To control this inflammatory process it has been proposed to apply antiproliferative drugs, via a paclitaxel coated balloon (DCB). The combination of DA and consecutively DCB has the potential to provide optimal vessel preparation and to improve drug uptake during balloon angioplasty.

top of page